Handelsbanken Fonder Ab Eli Lilly & CO Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Eli Lilly & CO stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 767,025 shares of LLY stock, worth $610 Million. This represents 2.69% of its overall portfolio holdings.

Number of Shares

767,025

Previous 758,099 1.18%

Holding current value

$610 Million

Previous $686 Million 1.0%

% of portfolio

2.69%

Previous 2.98%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	BUY	$772.14 - $960.02 $6.89 Million - $8.57 Million	8,926 Added 1.18%	767,025 $680 Million
Q2 2024 Aug 05, 2024	SELL	$724.87 - $909.04 $27.2 Million - $34.1 Million	-37,511 Reduced 4.71%	758,099 $686 Million
Q1 2024 May 13, 2024	SELL	$592.2 - $792.28 $24.7 Million - $33 Million	-41,638 Reduced 4.97%	795,610 $619 Million
Q4 2023 Feb 01, 2024	SELL	$525.19 - $619.13 $6.81 Million - $8.03 Million	-12,962 Reduced 1.52%	837,248 $488 Million
Q3 2023 Oct 19, 2023	SELL	$434.7 - $599.3 $32.1 Million - $44.2 Million	-73,738 Reduced 7.98%	850,210 $457 Million
Q2 2023 Aug 02, 2023	BUY	$350.74 - $468.98 $6.14 Million - $8.21 Million	17,514 Added 1.93%	923,948 $433 Million
Q1 2023 Apr 28, 2023	BUY	$310.63 - $364.82 $17.5 Million - $20.6 Million	56,444 Added 6.64%	906,434 $311 Million
Q4 2022 Feb 07, 2023	BUY	$321.55 - $374.67 $7.58 Million - $8.84 Million	23,585 Added 2.85%	849,990 $311 Million
Q3 2022 Oct 27, 2022	SELL	$296.48 - $337.87 $8.29 Million - $9.45 Million	-27,957 Reduced 3.27%	826,405 $267 Million
Q2 2022 Aug 03, 2022	SELL	$278.73 - $327.27 $16.2 Million - $19 Million	-57,965 Reduced 6.35%	854,362 $277 Million
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $30.9 Million - $38.4 Million	-131,549 Reduced 12.6%	912,327 $261 Million
Q4 2021 Feb 08, 2022	SELL	$224.85 - $279.04 $976,748 - $1.21 Million	-4,344 Reduced 0.41%	1,043,876 $288 Million
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $6.23 Million - $7.67 Million	28,132 Added 2.76%	1,048,220 $242 Million
Q2 2021 Aug 03, 2021	BUY	$180.55 - $233.54 $4.39 Million - $5.68 Million	24,300 Added 2.44%	1,020,088 $234 Million
Q1 2021 Apr 29, 2021	SELL	$164.32 - $212.72 $7.38 Million - $9.55 Million	-44,906 Reduced 4.32%	995,788 $186 Million
Q4 2020 Feb 11, 2021	BUY	$130.46 - $172.63 $6.46 Million - $8.55 Million	49,503 Added 4.99%	1,040,694 $176 Million
Q3 2020 Nov 13, 2020	BUY	$146.22 - $169.13 $10.4 Million - $12.1 Million	71,323 Added 7.75%	991,191 $147 Million
Q2 2020 Aug 13, 2020	BUY	$136.42 - $164.18 $15.2 Million - $18.3 Million	111,396 Added 13.78%	919,868 $151 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $12.3 Million - $15.2 Million	-102,997 Reduced 11.3%	808,472 $112 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $2.67 Million - $3.31 Million	24,983 Added 2.82%	911,469 $120 Million
Q3 2019 Oct 31, 2019	BUY	$106.79 - $116.16 $10.7 Million - $11.6 Million	100,000 Added 12.71%	886,486 $99.1 Million
Q2 2019 Jul 12, 2019	BUY	$110.79 - $129.32 $21.8 Million - $25.5 Million	197,076 Added 33.44%	786,486 $87.1 Million
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $24.1 Million - $28.3 Million	216,276 Added 57.96%	589,410 $76.5 Million
Q4 2018 Jan 31, 2019	BUY	$105.9 - $118.64 $1.38 Million - $1.54 Million	12,994 Added 3.61%	373,134 $43.2 Million
Q3 2018 Oct 23, 2018	BUY	$85.86 - $107.31 $30.9 Million - $38.6 Million	360,140 New	360,140 $38.6 Million
Q3 2018 Oct 19, 2018	SELL	$85.86 - $107.31 $27 Million - $33.7 Million	-314,140 Closed	0 $0
Q1 2018 May 18, 2018	BUY	$74.21 - $87.6 $371,049 - $438,000	5,000 Added 1.62%	314,140 $24.3 Million
Q4 2017 Feb 08, 2018	BUY	$81.94 - $87.89 $671,908 - $720,698	8,200 Added 2.72%	309,140 $26.1 Million
Q3 2017 Oct 24, 2017	BUY	$77.07 - $85.54 $23.2 Million - $25.7 Million	300,940	300,940 $25.7 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Eli Lilly & CO Transaction History